Failure of 3-methyladenine to modulate Semliki Forest virus replication in HeLa cells

Alphaviruses comprise approximately 30 viruses that cause a wide range of symptoms, from mild to severe. These viruses are classified into three main groups: aquatic, arthritogenic (affecting the joints), and encephalitic (causing brain inflammation). Infection with arthritogenic alphaviruses typically results in fever, rash, muscle and joint pain that can persist for months or even years. In contrast, encephalitic alphaviruses, such as Eastern equine encephalitis virus (EEEV) and Venezuelan equine encephalitis virus (VEEV), can lead to severe illness and potentially death. Currently, there are no specific antiviral drugs or vaccines available for these viruses. Understanding the cellular mechanisms that facilitate viral replication may provide new therapeutic targets. The role of autophagy in the replication of Semliki Forest virus (SFV) in HeLa cells remains unclear; therefore, it is important to investigate how 3-methyladenine (3-MA), an autophagy inhibitor, influences this process. In this study, I examined the effect of 3-MA on SFV replication in HeLa cells. Cells were infected with SFV and treated with 3-MA at defined time points. Viral titers were quantified using plaque assays and analyzed statistically. The results revealed no significant difference between the control and treated groups, suggesting that 3-MA does not significantly influence SFV proliferation in HeLa cells. This study contributes to the broader understanding of the role of 3-methyladenine in mammalian cells during alphavirus infection and underscores the need for further research in this area.